ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
33.95
Today's Change
-1.10 (3.13%)
Day's Change
33.73 - 35.17
Trading Volume
266,419
Market Cap
19 Billion
Shares Outstanding
586 Million
Avg Volume
461,572
Avg Price (50 Days)
33.36
Avg Price (200 Days)
28.68
PE Ratio
169.70
EPS
0.20
Earnings Announcement
27-Nov-2024
Previous Close
35.05
Open
35.06
Day's Range
33.73 - 35.175
Year Range
20.18 - 35.76
Trading Volume
266,817
1 Day Change
-3.20%
5 Day Change
-0.88%
1 Month Change
1.89%
3 Month Change
3.35%
6 Month Change
30.90%
Ytd Change
53.88%
1 Year Change
67.64%
3 Year Change
5.05%
5 Year Change
72.94%
10 Year Change
573.21%
Max Change
1296.30%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.